Clear Harbor Asset Management, LLC Chimerix Inc Transaction History

Clear Harbor Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 20, 2023	SELL	$1.67 - $2.35 $24,215 - $34,075	-14,500 Reduced 39.19%	22,500 $0
Q3 2022 Oct 24, 2022	SELL	$1.81 - $2.76 $43,440 - $66,240	-24,000 Reduced 39.34%	37,000 $71,000
Q2 2022 Jul 20, 2022	BUY	$1.34 - $5.34 $60,970 - $242,970	45,500 Added 293.55%	61,000 $127,000
Q1 2022 May 10, 2022	BUY	$4.58 - $6.8 $16,030 - $23,800	3,500 Added 29.17%	15,500 $71,000
Q4 2021 Jan 21, 2022	BUY	$5.23 - $7.18 $62,760 - $86,160	12,000 New	12,000 $77,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Clear Harbor Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Harbor Asset Management, LLC with notifications on news.